Transmission blocking vaccine studies in leishmaniasis: I Lipophosphogly can is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis | Zendy

Willy K. Tonui | Zendy; P. A. Mbati | Zendy; C. O. Anjili | Zendy; Alloys S. S. Orago | Zendy; S J Turco | Zendy; J. I. Githure | Zendy; D. K. Keoch | Zendy

Open Access

Transmission blocking vaccine studies in leishmaniasis: I Lipophosphogly can is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis

Author(s) -

Willy K. Tonui,

P. A. Mbati,

C. O. Anjili,

Alloys S. S. Orago,

S J Turco,

J. I. Githure,

D. K. Keoch

Publication year - 2001

Publication title -

east african medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.102

H-Index - 40

ISSN - 0012-835X

DOI - 10.4314/eamj.v78i2.9094

Subject(s) - phlebotomus , leishmania , leishmaniasis , psychodidae , cutaneous leishmaniasis , antigen , vector (molecular biology) , leishmania major , virology , biology , lutzomyia , transmission (telecommunications) , immunology , parasite hosting , microbiology and biotechnology , recombinant dna , biochemistry , electrical engineering , engineering , world wide web , computer science , gene

New strategies for control of leishmaniasis is needed as chemotherapy using antimonial drugs is prolonged, expensive, associated with side effects and relapses. Vector control has limitations and a vaccine which may be the best approach is not available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research